Zacks Company Profile for Smith & Nephew SNATS, Inc. (SNN : NYSE) |
|
|
|
Company Description |
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Number of Employees: 18,000 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $31.98 |
Daily Weekly Monthly
 |
20 Day Moving Average: 810,150 shares |
Shares Outstanding: 435.95 (millions) |
Market Capitalization: $13,941.74 (millions) |
Beta: 0.62 |
52 Week High: $44.47 |
52 Week Low: $29.40 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
-5.13% |
6.84% |
12 Week |
-6.65% |
2.61% |
Year To Date |
-7.63% |
11.35% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Roland Diggelmann - Chief Executive Officer
Roberto Quarta - Chairman
Anne-Francoise Nesmes - Chief Financial Officer
Vinita Bali - Director
Ian Barlow - Director
|
|
Peer Information
Smith & Nephew SNATS, Inc. (BJCT)
Smith & Nephew SNATS, Inc. (CADMQ)
Smith & Nephew SNATS, Inc. (APNO)
Smith & Nephew SNATS, Inc. (UPDC)
Smith & Nephew SNATS, Inc. (IMTIQ)
Smith & Nephew SNATS, Inc. (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 83175M205
SIC: 3842
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
|
|
Share - Related Items
Shares Outstanding: 435.95
Most Recent Split Date: 10.00 (2.50:1)
Beta: 0.62
Market Capitalization: $13,941.74 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 2.83% |
Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.90 |
Current Fiscal Year EPS Consensus Estimate: $1.73 |
Payout Ratio: |
Number of Estimates in the Fiscal Year Consensus: 2.00 |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: 8.29% |
Last Dividend Paid: 03/31/2022 - $0.45 |
Next EPS Report Date: - |
|
|
|
|